ACELYRIN
ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.
ACELYRIN
Industry:
Biopharma Biotechnology Health Care
Founded:
2020-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.acelyrin.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
258 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Advisors List
Current Employees Featured
Founder
Investors List
Westlake Village BioPartners
Westlake Village BioPartners investment in Series B - ACELYRIN
Samsara BioCapital
Samsara BioCapital investment in Series B - ACELYRIN
Marshall Wace
Marshall Wace investment in Series B - ACELYRIN
RTW Investments LLC
RTW Investments LLC investment in Series B - ACELYRIN
Surveyor Capital
Surveyor Capital investment in Series B - ACELYRIN
Matrix Capital Management
Matrix Capital Management investment in Series B - ACELYRIN
Tybourne Capital Management
Tybourne Capital Management investment in Series B - ACELYRIN
OrbiMed
OrbiMed investment in Series B - ACELYRIN
Decheng Capital
Decheng Capital investment in Series B - ACELYRIN
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - ACELYRIN
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-11 | ACELYRIN Appoints Melanie Gloria as Chief Operating Officer |
Official Site Inspections
http://www.acelyrin.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.97 K
- Host name: 52.142.5.13
- IP address: 52.142.5.13
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
